RxDoctor Payments Data

Christopher Borgiel, MD

Family Medicine · Fort Gratiot, MINPI 1316914245

Payments from drug & device makers

$11,321in general payments, 2019–2025

Across 744 payments — averaging $15.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • GSK$478
  • Amgen$460
  • plus $5K from 34 others

What the payments were for

  • Food & beverage$11,312100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,321 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$64,047
Medicare patients
158
Services billed
1,438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide39$50,250
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$45,389
OzempicSemaglutide30$38,029
MounjaroTirzepatide33$31,842
JanuviaSitagliptin Phosphate27$26,754
FarxigaDapagliflozin Propanediol14$19,204
EliquisApixaban15$15,093
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$10,058
LinzessLinaclotide11$8,417
ErythromycinErythromycin Base13$6,859
SymbicortBudesonide/Formoterol Fumarate16$5,445
Duloxetine Hcl33$5,141
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$3,365
Levothyroxine Sodium214$2,840
Risedronate Sodium19$2,729

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$1,082$82,09272 claims
GSKTrelegy Ellipta$478$45,38936 claims
Novo NordiskOzempic$1,290$38,02930 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,540$34,70842 claims
MerckJanuvia$338$26,75427 claims
PfizerEliquis$366$15,09315 claims
AbbVieLinzess$1,547$8,41711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Fort Gratiot

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →